Patients Want More Than FISH: Survey of 480 Myeloma and Precursor Patients Shows Strong Preference for Blood-Based Whole Genome Sequencing

Key Points

• Patients strongly prefer blood-based whole genome sequencing over FISH for assessing myeloma.
• Among 480 surveyed patients, a significant majority expressed dissatisfaction with FISH testing.
• The observational analysis gathered insights on patient preferences regarding genomic testing.
• This suggests a need for healthcare systems to adapt to patient demands for advanced genomic diagnostics.